#BEGIN_DRUGCARD DB02691

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
475-31-0

# ChEBI_ID:
29746

# Chemical_Formula:
C26H43NO6

# Chemical_IUPAC_Name:
2-[(4R)-4-[(1S,2S,5S,7R,9R,10R,11S,14S,15R,16R)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]acetic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
The glycine conjugate of cholic acid. It acts as a detergent to solubilize fats for absorption and is itself absorbed. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Cholagogues and Choleretics
Detergents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
1.65

# Experimental_Logs:
-5.15

# Experimental_Water_Solubility:
3.3 mg/L (at 20 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-Cholylglycine

# HET_ID:
GCH

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15-,16+,17+,18+,19+,20-,21-,24+,25+,26-/m1/s1

# InChI_Key:
InChIKey=RFDAIACWWDREDC-YUHACDEOSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C01921

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2691

# Mechanism_Of_Action:
Not Available

# Melting_Point:
166.5 °C

# Molecular_Weight_Avg:
465.6227

# Molecular_Weight_Mono:
465.309038113

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1EIO

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.7

# Predicted_LogS:
-4.3

# Predicted_Water_Solubility:
2.48e-02 g/l

# Primary_Accession_No:
DB02691

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936456

# PubChem_Substance_ID:
46507924

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01558

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@H](CCC(=O)NCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3C[C@@H](O)[C@]12C

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-03-02 17:08:57 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
FABP6

# Drug_Target_1_GenBank_ID_Gene:
U19869

# Drug_Target_1_GenBank_ID_Protein:
894183

# Drug_Target_1_GeneCard_ID:
FABP6

# Drug_Target_1_Gene_Name:
FABP6

# Drug_Target_1_Gene_Sequence:
>387 bp
ATGGCTTTCACCGGCAAGTTCGAGATGGAGAGTGAGAAGAATTATGATGAGTTCATGAAG
CTCCTTGGGATCTCCAGCGATGTAATCGAAAAGGCCCGCAACTTCAAGATCGTCACGGAG
GTGCAGCAGGATGGGCAGGACTTCACTTGGTCCCAGCACTACTCCGGGGGCCACACCATG
ACCAACAAGTTCACTGTTGGCAAGGAAAGCAACATACAGACAATGGGGGGCAAGACGTTC
AAGGCCACTGTGCAGATGGAGGGCGGGAAGCTGGTGGTGAATTTCCCCAACTATCACCAG
ACCTCAGAGATCGTGGGTGACAAGCTGGTGGAGGTCTCCACCATCGGAGGCGTGACCTAT
GAGCGCGTGAGCAAGAGACTGGCCTAA

# Drug_Target_1_General_Function:
Involved in bile salt transporter activity

# Drug_Target_1_General_References:
7588781	Fujita M, Fujii H, Kanda T, Sato E, Hatakeyama K, Ono T: Molecular cloning, expression, and characterization of a human intestinal 15-kDa protein. Eur J Biochem. 1995 Oct 15;233(2):406-13.
7619861	Oelkers P, Dawson PA: Cloning and chromosomal localization of the human ileal lipid-binding protein. Biochim Biophys Acta. 1995 Jul 13;1257(2):199-202.

# Drug_Target_1_HGNC_ID:
HGNC:3561

# Drug_Target_1_HPRD_ID:
02689

# Drug_Target_1_ID:
3587

# Drug_Target_1_Locus:
5q33.3-q34

# Drug_Target_1_Molecular_Weight:
14371

# Drug_Target_1_Name:
Gastrotropin

# Drug_Target_1_Number_of_Residues:
128

# Drug_Target_1_PDB_ID:
1O1V

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00061	Lipocalin

# Drug_Target_1_Protein_Sequence:
>Gastrotropin
MAFTGKFEMESEKNYDEFMKLLGISSDVIEKARNFKIVTEVQQDGQDFTWSQHYSGGHTM
TNKFTVGKESNIQTMGGKTFKATVQMEGGKLVVNFPNYHQTSEIVGDKLVEVSTIGGVTY
ERVSKRLA

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Ileal protein which stimulates gastric acid and pepsinogen secretion. Seems to be able to bind to bile salts and bilirubins

# Drug_Target_1_SwissProt_ID:
P51161

# Drug_Target_1_SwissProt_Name:
FABP6_HUMAN

# Drug_Target_1_Synonyms:
GT
I-15P
I-BABP
ILBP
Ileal lipid-binding protein
Intestinal 15 kDa protein
Intestinal bile acid-binding protein

# Drug_Target_1_Theoretical_pI:
6.81

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02691
